HighCape Capital’s SPAC goes public

HighCape Capital Acquisition Corp, a blank check company formed by HighCape Capital targeting the life sciences industry, has debuted its IPO after pricing its 10 million shares at $10 per share.

To view this content, you need to sign in.


You should only be asked to sign in once. Not the case? Click here


Register now to access this content and more for free.

Share this